Idoven

Idoven is a health technology startup based in Spain, founded in 2018. The company's mission is to redefine the way cardiovascular diseases are detected and treated using Artificial Intelligence (AI). Their AI-powered platform, certified as EU MDR Medical Device Class IIa, significantly enhances the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The company's software is designed to seamlessly integrate into existing clinical and research workflows, supporting clinician decision-making and disease management. Idoven has received recognition for its AI technology in Europe and the US, including the European Innovation Council (EIC) Accelerator, Horizon 2020 (H2020) awards, and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company has garnered support from prominent investors such as Insight Partners, Northzone, Hambro Perks, Gasol16 Ventures, Adam Chekroud, and Luis Sanz. As of 05 September 2023, Idoven secured a Venture Round investment, demonstrating continued confidence from investors in the company's innovative approach to cardiovascular care. With its strong investor support and cutting-edge technology, Idoven is poised to make a significant impact in the Health Care industry.